Prosecution Insights
Last updated: July 17, 2026
Application No. 17/281,711

A Bioreactor System

Non-Final OA §103
Filed
Mar 31, 2021
Priority
Oct 17, 2018 — GB 1816897.1 +2 more
Examiner
ORLANDO, AMBER ROSE
Art Unit
1700
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Global Life Sciences Solutions USA LLC
OA Round
6 (Non-Final)
64%
Grant Probability
Moderate
6-7
OA Rounds
0m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allowance Rate
429 granted / 671 resolved
-1.1% vs TC avg
Strong +29% interview lift
Without
With
+28.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
9 currently pending
Career history
677
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
83.1%
+43.1% vs TC avg
§102
5.9%
-34.1% vs TC avg
§112
2.2%
-37.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 671 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 02/06/2026 has been entered. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-9 and 19 is/are rejected under 35 U.S.C. 103 as being unpatentable over Jones et al. US 201600096131 in view of Pitt et al. US 5,094,675. For claim 1 the Jones et al. reference discloses a method for removing exhaust gas from a bioreactor (par 005) including the steps of providing at least one exhaust filter (74) connected to an outlet (65) of the bioreactor for transferring exhaust gas out from the bioreactor and increasing a pressure at an outlet side of the at least one exhaust filter, thereby increasing a pressure differential across the at least one exhaust filter (paragraph 0062, 0063 “one option is to increase the gas pressure on the upstream side of filter 74”, “casing 70… safely withstanding higher gas pressures” ). The reference does not disclose using a pressure controlling device provided upstream of the exhaust filter. The Pitt et al. reference is also related to creating pressure differences across a filter element and discloses a pressure controlling device provided upstream of the exhaust filter (Pitt et al. column 4 lines 46-53). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified the Jones et al. reference to include a pressure controlling device provided upstream of the exhaust filter (Pitt et al. column 4 lines 46-53) as the location of the pressure inducing source is of no consequence as long as there is the pressure differential across the filtration element. Further the courts have held that that rearranging parts of an invention involves only routine skill in the art. In re Japikse, 86 USPQ 70. Regarding to claim 3, Jones et al teach the step of providing a pressure controlling device (185, paragraph 0066-0068) such as applying a partial vacuum or negative pressure to the exhaust port (65) of filter (74) so that the applied pressure increases the flow rate of gas through the filter (74f) and increasing a pressure differential across the at least one exhaust filter (paragraph 0065). To note by decreasing a pressure at an outlet side of the at least one exhaust filter this would increase the pressure at the inlet side of the at least one exhaust filter. Regarding to claim 4, Jones et al further teach the steps of measuring the pressure in the bioreactor (paragraph 0069) via a pressure gauge (189), controlling the pressure controlling device (185) to provide different amount of pressure decrease to the outlet side of the at least one exhaust filter (74) or pressure increase to the inlet side of the at least one exhaust filter (74) in dependence of the measured pressure in the bioreactor (see paragraphs 0066-0070). Regarding to claim 5, Jones et al teach the bioreactor comprising a flexible bioreactor bag (paragraphs 0007 & 0031). Regarding to claim 6, Jones et al teach the bioreactor being a single-use bioreactor (paragraph 0029). Regarding to claim 7, Jones et al further teach the step of providing gas into the bioreactor through an inlet filter (74A, paragraphs 0046-0048). Regarding to claim 8, Jones et al further teach the steps of providing first and second filters (66C, 66D, 66E in Fig. 5) connected in parallel via one valve (220A, 220B,220C in Fig. 5) and connecting first the first filter through the outlet valve and when the first filter is clogged connect the second filter to the outlet via one valve (paragraph 0073). Regarding to claim 9, Jones et al teach the pressure controlling device (185) being a pump or fan. As shown above, Pitt et al. discloses a fan. Regarding to claim 19, Jones et al teach a control system configured for being connected to a pressure control device (185, paragraphs 0066-0068) in the bioreactor system configured to perform the method according to claim 8 wherein the control system (190) is configured to be connected to a pressure sensor (189, paragraph 0069) for measuring a pressure in the bioreactor and wherein the control system (190, paragraphs 0071 & 0072) comprises software for controlling the pressure controlling device (185) to provide different amount of pressure increase to the inlet side of the at least one exhaust filter (74) in dependence of the pressure measured by the pressure sensor (see paragraphs 0062-0065). Response to Arguments Applicant’s arguments with respect to claim(s) 1, 3-9 and 19 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMBER ROSE ORLANDO whose telephone number is (571)270-3149. The examiner can normally be reached Monday-Thursday 6:30-4:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alexa Neckel can be reached at (571) 272-2450. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. AMBER ROSE ORLANDO Primary Examiner Art Unit 1731 /AMBER R ORLANDO/Primary Examiner, Art Unit 1731
Read full office action

Prosecution Timeline

Show 12 earlier events
Sep 09, 2025
Response Filed
Sep 09, 2025
Response after Non-Final Action
Sep 25, 2025
Response Filed
Dec 12, 2025
Final Rejection mailed — §103
Jan 27, 2026
Response after Non-Final Action
Feb 06, 2026
Request for Continued Examination
Feb 09, 2026
Response after Non-Final Action
Jun 23, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678730
MIXED GAS SEPARATION METHOD AND MIXED GAS SEPARATION DEVICE
3y 0m to grant Granted Jul 14, 2026
Patent 12662403
PHOTOSWITCHABLE GUANIDINIUM COMPOUNDS FOR REMOVAL OF OXYANIONS FROM LIQUID SOLUTIONS
3y 11m to grant Granted Jun 23, 2026
Patent 12661612
CARBON DIOXIDE RECOVERY SYSTEM
3y 2m to grant Granted Jun 23, 2026
Patent 12584201
ITEM MADE OF PRECIOUS CERMET
3y 9m to grant Granted Mar 24, 2026
Patent 11071313
PALM-BASED ANIMAL FEED
5y 11m to grant Granted Jul 27, 2021
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

6-7
Expected OA Rounds
64%
Grant Probability
93%
With Interview (+28.7%)
2y 11m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 671 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month